Trivora
Product Images NDC 54868-4239

4 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Trivora (NDC 54868-4239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Package Label (4239)

Image Of Package Label (4239)
Packaging label for Trivora-28 oral tablets distributed by Physicians Total Care, Inc. The label includes product NDC 54868-4239-0, package count of 28 tablets, lot number 0000, and an expiration date listed as 01/60. Manufactured by Apotex, Inc. in Mississauga, Ontario.*
FDA Label Image

Bcd8e14b-figure-01 (Trivora 1)

Bcd8e14b-figure-01 (Trivora 1)
Chemical structure diagrams of Levonorgestrel and Ethinyl Estradiol, the active ingredients in Trivora by Physicians Total Care, Inc. Each structure shows the molecular configuration with labeled elements and bonds.*
FDA Label Image

Bcd8e14b-figure-02 (Trivora 2)

Bcd8e14b-figure-02 (Trivora 2)
A bar chart showing data categorized by age groups (15-24, 25-34, 35-44, 45+) and smoking status (ever-users and controls, smoking and non-smoking). The chart compares frequency counts across these categories, with the tallest bar representing ever-users who are smokers aged 45 and older.*
FDA Label Image

Trivora Blister Pack Image (Trivora 3)

Trivora Blister Pack Image (Trivora 3)
An instructional diagram depicting a 28-day triphasic regimen for Trivora, showing a calendar layout with arrows guiding through days of the week across four rows labeled K, U, E, and W. Each day has a circular placeholder representing a tablet, with the note that tablets in week 4 are inactive. The regimen includes levonorgestrel and ethinyl estradiol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.